The Enlarged Board of Appeal of the European Patent Office issued opinion G 3/19 (Pepper) today 14 May 2020 and concluded that plants and animals exclusively obtained by essentially biological processes are not patentable.
The UK IPO and EPO remain “open for business” during the coronavirus outbreak with some deadlines extended.
Video conferencing rather than a visit to Munich or the Hague is now the default for examining division oral proceedings. Lisa Brown discusses the recent change of policy at the EPO.
An April update on the latest news from the UK Intellectual Property Office and European Patent Office.
In this article, Associate Dr Liam Lawlor reviews how the EPO considers medical use claims, before looking more closely at patenting personalised medicines at the EPO.
